Table 1

Descriptive analysis of HDL-C testing and lipid-lowering scripts in the stable target population in 2014

Demographics	Population size	Estimated HDL-C tests		Lipid-lowering scripts
Demographics	Population size	Total	Per 1000 population	Total	Per 1000 population
Total	2 395 340	1 628 477	680	22 726 283	9488
Gender
Female	1 155 602	772 323	668	11 060 756	9571
Male	1 239 738	856 154	691	11 665 527	9410
Age group
18–34	8 600	6 475	753	55 578	6463
35–44	46 563	34 488	741	327 483	7033
45–54	192 809	128 795	668	1 515 479	7860
55–64	491 589	325 797	663	4 225 698	8596
65–74	756 266	523 975	693	7 335 472	9700
≥75	899 513	608 947	677	9 266 572	10 302
States
NSW+ACT	859 266	601 207	700	8 148 928	9484
VIC+TA	655 626	458 551	699	6 230 681	9503
SA+NT	209 346	122 986	587	2 025 266	9674
QLD	447 170	310 464	694	4 218 660	9434
WA	223 932	135 269	604	2 102 747	9390

ACT, Australia Capital Territory; HDL-C, high-density lipoprotein cholesterol; NSW, New South Wales; NT, Northern Territory; QLD, Queensland; SA, South Australia; TA, Tasmania; VIC, Victoria; WA, Western Australia.